Results 1 to 10 of about 7,128 (244)
Suppressor of Cytokine Signaling 1–Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice [PDF]
, 2014 Carlota Recio +5 more
openalex +1 more source
Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab [PDF]
, 2022 Nali Yang +5 more
openalex +1 more source
Profile of pacritinib and its potential in the treatment of hematologic disorders
Journal of Blood Medicine, 2014 Eleftheria Hatzimichael, Evangelos Tsolas, Evangelos Briasoulis Department of Haematology, University Hospital of Ioannina, Ioannina, Greece Abstract: Pacritinib (previously known as SB-1518) is an innovative selective inhibitor of Janus kinase 2 and ...
Hatzimichael E, Tsolas E, Briasoulis E
doaj
Dermatology and TherapyAlopecia areata is an inflammatory autoimmune disease that presents as non-scarring hair loss in adults and children and causes substantial psychological distress, economic burden, and reduced quality of life for those affected.
Hussein Abdel Dayem +10 more
doaj +1 more source
Constitutive NF-κB Activation Confers Interleukin 6 (IL6) Independence and Resistance to Dexamethasone and Janus Kinase Inhibitor INCB018424 in Murine Plasmacytoma Cells [PDF]
, 2011 Yanqiang Yang +5 more
openalex +1 more source
Advances in Myelofibrosis Management: New Janus Kinase Inhibitors Beyond Ruxolitinib [PDF]
Justin Arnall +2 more
openalex +1 more source
Open MedicineThis meta-analysis evaluates Janus Kinase (JAK) inhibitors’ efficacy and safety in large vessel vasculitis (LVV), encompassing Giant Cell Arteritis (GCA) and Takayasu’s Arteritis (TAK).
Bai Yang, Wang Zhe, Zhang Chunling
doaj +1 more source